-
integrationacademy.ahrq.gov/products/topic-briefs/pregnant-postpartum-women
December 01, 2024 - Practices can also incorporate psychologists, psychiatrists, social workers, substance use counselors
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-0242-fullreport.pdf
February 01, 2020 - Follow-up Visits for Children Who Are Obese or Overweight with a Weight-Related Comorbidity: Report
1
Follow-up Visits for Children Who Are Obese or
Overweight with a Weight-Related Comorbidity
Section 1. Basic Measure Information
1.A. Measure Name
Follow-up Visits for Children Who Are Obese or Overweight wi…
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-230-fullreport.pdf
July 01, 2019 - CHIPRA 230: Documentation of BMI Percentile and Weight Classification for Children
1
Documentation of BMI Percentile and Weight
Classification for Children
Section 1. Basic Measure Information
1.A. Measure Name
Documentation of BMI Percentile and Weight Classification for Children
1.B. Measure Number
0230
1…
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/preventive/chipra-0090-fullreport.pdf
July 25, 2016 - Tobacco Use and Help With Quitting Among Adolescents
Tobacco Use and Help With Quitting Among
Adolescents
Section 1. Basic Measure Information
1.A. Measure Name
Tobacco Use and Help With Quitting Among Adolescents
1.B. Measure Number
0090
1.C. Measure Description
Please provide a non-technical description …
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/duration/chipra-156-fullreport.pdf
June 01, 2018 - Continuity of Insurance: Duration of First Observed Enrollment
1
Continuity of Insurance: Duration of First Observed
Enrollment
Section 1. Basic Measure Information
1.A. Measure Name
Continuity of Insurance: Duration of First Observed Enrollment
1.B. Measure Number
0156
1.C. Measure Description
Please …
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/duration/chipra-153-fullreport.pdf
May 23, 2018 - Continuity of Insurance: Informed Participation
1
Continuity of Insurance: Informed Participation
Section 1. Basic Measure Information
1.A. Measure Name
Continuity of Insurance: Informed Participation
1.B. Measure Number
0153
1.C. Measure Description
Please provide a non-technical description of the me…
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/duration/chipra-155-fullreport.pdf
September 01, 2018 - Continuity of Insurance: Coverage Presumed Ineligible
1
Continuity of Insurance: Coverage Presumed
Ineligible
Section 1. Basic Measure Information
1.A. Measure Name
Continuity of Insurance: Coverage Presumed Ineligible
1.B. Measure Number
0155
1.C. Measure Description
Please provide a non-technical d…
-
www.ahrq.gov/sites/default/files/2024-10/kennerly-ballard-report.pdf
January 01, 2024 - Final Progress Report: Adverse Event-Directed Analysis in Ambulatory Primary Care
Adverse Event-Directed Analysis in Ambulatory Primary
Care Final Report
September 30, 2009
Principal Investigator: Donald Kennerly, MD, PhD
Team Members:
David Ballard, MD, MSPH, PhD, Co-Investigator
S. Quay Mercer, BS, MT (ASCP…
-
www.ahrq.gov/sites/default/files/2024-01/bailey-kilbridge-report.pdf
January 01, 2024 - Final Progress Report: Surveillance for Adverse Drug Events in Ambulatory Pediatrics
1. Title: Surveillance for Adverse Drug Events in Ambulatory Pediatrics
Principal Investigator(s): Thomas C. Bailey (07/15/09—02/28/11)
Peter M. Kilbridge (09/01/07—07/14/09)
Team Members: Laura A. Noirot
Richard M. Reichley
…
-
www.ahrq.gov/sites/default/files/wysiwyg/funding/training-grants/eric-roberts-draft-application.pdf
May 19, 2021 - Eric T. Roberts - Sample Grant Application
PI: Roberts, Eric T Title: Financial assistance for low-income Medicare beneficiaries: Using natural
experiments to assess effects on care and health outcomes
Received: 05/29/2018 FOA: PA16-223
Clinical Trial:Optional
Council: 01/2019
Competition ID: FORMS-E FOA…
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/CXDusYW7s2xdypXMpnW9sw
June 20, 2023 - Anxiety Screening: Evidence Report and Systematic Review for the US Preventive Services Task Force
Anxiety Screening
Evidence Report and Systematic Review
for the US Preventive Services Task Force
Elizabeth A. O’Connor, PhD; Michelle L. Henninger, PhD; Leslie A. Perdue, MPH; Erin L. Coppola, MPH;
Rachel G. Thomas, MP…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/episodic-migraine-surveillance-report-2.pdf
June 01, 2022 - Acute Treatment for Episodic Migraine: Surveillance Report 2
Acute Treatments for Episodic Migraine:
Surveillance Report 2
Literature Update Period: September 2, 2021, Through December 30, 2021
Background and Purpose
This report is the second surveillance report for the Agency for Healthcare Research and
Quali…
-
integrationacademy.ahrq.gov/products/topic-briefs/behavioral-health-apps
July 01, 2024 - An official website of the Department of Health & Human Services
Search All AHRQ Sites
Careers
Contact Us
Español
FAQs
Email Updates
The Academy
Integrating Behavioral Health & Primary Care
Expand Navi…
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/low-dose-aspirin-use-for-the-prevention-of-morbidity-and-mortality-from-preeclampsia-preventive-medication
September 28, 2021 - Share to Facebook
Share to X
Share to WhatsApp
Share to Email
Print
Evidence Summary
Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: Preventive Medication
September 28, 2021
Recommendations made by the USPSTF are indepe…
-
digital.ahrq.gov/sites/default/files/docs/citation/cds-evaluation-summary-report-p233201500023I.pdf
March 23, 2022 - Evaluation of the Agency for Healthcare Research and Quality Patient-Centered Outcomes Research Clinical Decision Support Initiative: Findings and Recommendations for Future Initiatives
Summary Report
Evaluation of the Agency
for Healthcare Research
and Quality Patient-
Centered Outcomes
Research Clinical Decisi…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/migraine-prevention_executive.pdf
June 01, 2013 - 1
Comparative Effectiveness Review
Number 108
Migraine in Children:
Preventive Pharmacologic Treatments
Executive Summary
Introduction
The Agency for Healthcare Research
and Quality (AHRQ) commissioned the
Minnesota Evidence-based Practice
Center (EPC) to conduct a review of
preventive pharmacologic treatm…
-
effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/alcohol-pharma-final-protocol.pdf
January 01, 2023 - Pharmacotherapy for Adults With Alcohol-Use Disorders in Outpatient Settings: Systematic Review Update
Evidence-based Practice Center Systematic Review Protocol
Project Title: Pharmacotherapy for Adults With Alcohol-Use Disorders in
Outpatient Settings: Systematic Review Update
I. Background and Object…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/mrsa-screening-2010_executive.pdf
January 01, 2010 - 1
Comparative Effectiveness Review
Number 102
Screening for Methicillin-Resistant
Staphylococcus Aureus (MRSA)
Executive Summary
Background
Methicillin-resistant Staphylococcus
aureus (MRSA) emerged as a clinically
relevant human pathogen more than
five decades ago.1 The virulent bacterium
was first detecte…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/sodium-potassium_research-protocol.pdf
April 18, 2017 - Effects of Dietary Sodium and Potassium Intake on Chronic Disease
Evidence-based Practice Center Systematic Review Protocol
Project Title: Effects of Dietary Sodium and Potassium Intake on Chronic Disease …
-
effectivehealthcare.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1412.pdf
October 01, 2015 - PULMONARY with "Discussions" in Exec Summary
AHRQ Healthcare Horizon Scanning System – Potential
High-Impact Interventions Report
Priority Area 13: Pulmonary Disease, Including Asthma
Prepared for:
Agency for Healthcare Research and Quality
U.S. Department of Health and Human Services
540 Gaither Ro…